Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema

Ophthalmologica

Volumn 227, Issue 2, 2012, Pages 95-99

  Sobaci, Güngör ^a   Özge, Gökhan ^a   Erdurman, Cüneyt ^a   Durukan, Hakan A ^a   Bayraktar, Zeki M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bevacizumab; Diabetic macular edema; Laser photocoagulation; Triamcinolone acetonide

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIFFUSE DIABETIC MACULAR EDEMA; FOLLOW UP; GRID LASER PHOTOCOAGULATION; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; LASER COAGULATION; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; SIDE EFFECT; TRABECULECTOMY; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MIDDLE AGED; RETINA; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84856486184     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000331322     Document Type: Article

References (17)

1. Diabetic Retinopathy Clinical Research Network (DRCR.net): Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009;127:245-251.
2. Diabetic Retinopathy Clinical Research Network (DRCR.net): Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077.
3. Michaelides M, Kaines A, Hamilton R-grave, et al: A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 2010;117:1078-1086.
4. Kreutzer TC, Al Saeidi R, Kook D, et al: Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema. Ophthalmologica 2010;224:258-264.
5. Macugen Diabetic Retinopathy Study Group: A phase II randomized doublemasked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005;112:1747-1757.
6. Diabetic Retinopathy Clinical Research Network: Comparison of Modified-ET-graveRS and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular Edema. Arch Ophthalmol 2007;125:469-480.
7. Diabetic Retinopathy Clinical Research Network: Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol 2008;145:894-901.
8. Diabetic Retinopathy Clinical Research Network Study Group: Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008;115:1366-1371.
9. Early Treatment Diabetic Retinopathy Study Research Group: Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ET-graveRS report No. 19. Arch Ophthalmol 1995;113:1144-1155.
10. Diabetic Retinopathy Clinical Research Network: A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-1449.
11. Aiello LP, Edwards AR, Beck RW, et al: Diabetic Retinopathy Clinical Research Network. Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2010;117:946-953.
12. Arevalo JF, Sanchez JG, Fromow-Guerra J, et al: Pan-American Collaborative Retina Study Group (PACORES). Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up. Graefes Arch Clin Exp Ophthalmol 2009;247:735-743.
13. Goyal S, Lavalley M, Subramanian ML: Metaanalysis and review on the effect of bevacizumab in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2011;249:15-27.
14. Grover D, Li TJ, Chong CC: Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev 2008;1: C-grave005656.
15. Solaiman KA, Diab MM, Abo-Elenin M: Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Retina 2010;30:1638-1645.
16. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A; RESTORE study group: The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-625.
17. Diabetic Retinopathy Clinical Research Network; Writing Committee, Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK: Expanded 2-year followup of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011;118:609-614.